HomeCLBIO • STO
add
Corline Biomedical AB
Previous close
kr 10.10
Day range
kr 9.70 - kr 10.05
Year range
kr 5.98 - kr 15.00
Market cap
246.13M SEK
Avg Volume
25.26K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 2.44M | -71.99% |
Operating expense | 5.60M | -28.30% |
Net income | -14.16M | -2,260.17% |
Net profit margin | -579.42 | -8,321.80% |
Earnings per share | — | — |
EBITDA | -4.13M | -613.13% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 17.67M | 3.86% |
Total assets | 94.76M | -5.34% |
Total liabilities | 7.85M | 15.60% |
Total equity | 86.91M | — |
Shares outstanding | 24.49M | — |
Price to book | 2.85 | — |
Return on assets | -11.07% | — |
Return on capital | -12.12% | — |
Cash Flow
Net change in cash
(SEK) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -14.16M | -2,260.17% |
Cash from operations | -5.80M | -339.10% |
Cash from investing | -432.00K | 82.11% |
Cash from financing | 16.57M | — |
Net change in cash | 10.33M | 86,016.67% |
Free cash flow | -4.67M | -2,095.62% |
About
Founded
1991
Website
Employees
13